Equasens SA
PAR:EQS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Equasens SA
PAR:EQS
|
FR |
|
F
|
Forth Corporation PCL
SET:FORTH
|
TH |
|
V
|
Victorian Plumbing Group PLC
F:637
|
UK |
Intrinsic Value
The intrinsic value of Equasens SA (EQS) under the Base Case is 37.48 EUR per share.
Compared with the current market price of 29.55 EUR, the stock appears
Undervalued by 21% .
The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about 6% a year over the next five years, against 7% over the last five, and net margin stays near last year's 17%. If net margin stayed at its five-year average of 19%, the estimate would be about €43.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Equasens Does
Equasens SA is a French software and technology company focused on the healthcare sector. It builds and sells digital tools that help pharmacies, doctors, nurses, hospitals, and care facilities manage prescriptions, patient records, billing, and day-to-day administration. Its products are designed to sit inside the workflow of healthcare professionals, so the company is less of a general IT vendor and more of a specialist provider for regulated medical and pharmacy businesses.
- Headquarters
- France FR
- Employees
- 1 400
- IPO date
- Oct 20, 2000
Equasens has no economic moat
Equasens SA lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Equasens SA
The intrinsic value for Equasens SA (EQS) under the Base Case is 37.48 EUR.
Compared with the current market price of 29.55 EUR, the stock appears Undervalued by 21% .